Match!
Michael Drummond
University of York
Health carePhysical therapyHealth technologyEconomic evaluationMedicine
656Publications
73H-index
32.8kCitations
What is this?
Publications 636
Newest
#1Michael Drummond (Ebor: University of York)H-Index: 73
#2C. Daniel MullinsH-Index: 19
Last. C. Daniel Mullins (UMB: University of Maryland, Baltimore)H-Index: 32
view all 2 authors...
Source
#1Michael Drummond (Ebor: University of York)H-Index: 73
Source
#1M. Venhart (SAV: Slovak Academy of Sciences)H-Index: 3
#2M. Balogh (SAV: Slovak Academy of Sciences)H-Index: 2
Last. M. C. Drummond (University of Liverpool)H-Index: 4
view all 43 authors...
Abstract The extremely neutron-deficient isotopes 177,179Au were studied by means of in-beam γ-ray spectroscopy. Specific tagging techniques, α-decay tagging in 177Au and isomer tagging in 179Au, were used for these studies. Feeding of positive-parity, nearly spherical states, which are associated with 2 d 3 / 2 and 3 s 1 / 2 proton-hole configurations, from the 1 i 13 / 2 proton-intruder configuration was observed in 177Au. Such a decay path has no precedent in odd-Au isotopes and it is explain...
Source
#1Carlo FedericiH-Index: 4
Last. Michael DrummondH-Index: 73
view all 4 authors...
Source
#1Michael Drummond (Ebor: University of York)H-Index: 73
#2Aleksandra Torbica (Bocconi University)H-Index: 18
Last. Rosanna Tarricone (Bocconi University)H-Index: 22
view all 3 authors...
Source
#1Michela Meregaglia (Bocconi University)H-Index: 6
#2Amanda Whittal (Bocconi University)
Last. Michael Drummond (Ebor: University of York)H-Index: 73
view all 4 authors...
The use of patient-reported outcome measures (PROMs) to monitor the effects of disease and treatment on patient symptomatology and daily life is increasing in rare diseases (RDs) (i.e. those affecting less than one in 2000 people); however, these instruments seldom yield health state utility values (HSUVs) for cost-utility analyses. In such a context, ‘mapping’ allows HSUVs to be obtained by establishing a statistical relationship between a ‘source’ (e.g. a disease-specific PROM) and a ‘target’ ...
Source
#2Lisa CaulleyH-Index: 6
Last. Ricard MeneuH-Index: 2
view all 13 authors...
Introduction There has been a growing awareness of the need for rigorously and transparent reported health research, to ensure the reproducibility of studies by future researchers. Health economic evaluations, the comparative analysis of alternative interventions in terms of their costs and consequences, have been promoted as an important tool to inform decision-making. The objective of this study will be to investigate the extent to which articles of economic evaluations of healthcare intervent...
1 CitationsSource
#1Vivian Reckers-Droog (EUR: Erasmus University Rotterdam)H-Index: 2
#2Carlo Federici (Warw.: University of Warwick)H-Index: 4
Last. Michael Drummond (Ebor: University of York)H-Index: 73
view all 4 authors...
ABSTRACT Objectives Coverage with evidence development (CED) schemes are particularly relevant for medical devices (MDs), since clinical evidence is often limited at the time of launch and their long-term (cost-) effectiveness heavily depends on how they are adopted into routine clinical practice. The objective of this study was to identify and describe the challenges that payers and manufacturers might face when assessing the desirability of, choosing the research design for, implementing, and ...
Source
#1B Corbacho (Ebor: University of York)H-Index: 11
#1B. Corbacho (Ebor: University of York)
Last. A. PratH-Index: 1
view all 9 authors...
Objectives: A centralised approach to health technology assessment (HTA) may facilitate optimal use of HTA resources. A regional approach may increase the chances of local implementation of recommendations. This study aimed to compare assessment procedures in England (centralised HTA approach) with Spain (regional HTA approach) discussing key challenges and opportunities from both approaches. Methods: We compared technology assessments of anticancer medicines in the two jurisdictions from 2008 t...
1 CitationsSource
#1L. Capponi (University of the West of Scotland)H-Index: 3
#1L. CapponiH-Index: 4
Last. Juha Uusitalo (University of Jyväskylä)H-Index: 29
view all 36 authors...
Source
12345678910